跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 27,948 条关于
“Blue Harbour Asset Management”
全部
27,948
临床试验
18,092
药物
239
机构
265
资讯
9,352
去年
Titan Pharmaceuticals Secures $1.6 Million in Strategic Funding Through Two Convertible Preferred Stock Placements
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
6个月前
Blue Light Cystoscopy Shows Superior Detection and Cost-Effectiveness in High-Risk Bladder Cancer Management
9个月前
Harbour BioMed Expands AstraZeneca Partnership for Next-Generation Oncology Therapeutics
6个月前
Harbour BioMed and Kelun-Biotech Receive NMPA Approval for Novel Bispecific Antibody Targeting Atopic Dermatitis
去年
Harbour BioMed Forges Strategic AI Partnership with Insilico Medicine for Antibody Discovery
去年
Blue Cross Blue Shield of Massachusetts to End Coverage for Weight Loss GLP-1 Drugs in 2026
3个月前
Harbour BioMed and BioMap Launch MegaStream TechBio to Build AI-Native Complex Biologics Platform
3个月前
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Jury Awards $20.2 Million
去年
Blue Light Cystoscopy Reduces Bladder Cancer Recurrence in Veterans
第 1 页，共 936 页
上一页
下一页
